Andrzej Hellmann

7.7k total citations · 3 hit papers
130 papers, 4.0k citations indexed

About

Andrzej Hellmann is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Andrzej Hellmann has authored 130 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Hematology, 39 papers in Genetics and 26 papers in Immunology. Recurrent topics in Andrzej Hellmann's work include Chronic Lymphocytic Leukemia Research (28 papers), Chronic Myeloid Leukemia Treatments (25 papers) and Eosinophilic Disorders and Syndromes (15 papers). Andrzej Hellmann is often cited by papers focused on Chronic Lymphocytic Leukemia Research (28 papers), Chronic Myeloid Leukemia Treatments (25 papers) and Eosinophilic Disorders and Syndromes (15 papers). Andrzej Hellmann collaborates with scholars based in Poland, United States and United Kingdom. Andrzej Hellmann's co-authors include Maria Bieniaszewska, Jolanta Myśliwska, Piotr Trzonkowski, Anna Dmoszyńska, Natalia Marek-Trzonkowska, Adam Krzystyniak, Anita Dobyszuk, Meletios Α. Dimopoulos, Robin Foà and Robert Knight and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Andrzej Hellmann

122 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

2007 1.1k citations Anna Dmoszyńska, Andrzej Hellmann et al. profile →
First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127− T regulatory cells

2009 535 citations Piotr Trzonkowski, Maria Bieniaszewska et al. profile →
Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

2012 457 citations Andrzej Hellmann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrzej Hellmann Poland	24	2.0k	1.1k	1.1k	940	834	130	4.0k
Dominik Heim Switzerland	33	1.9k 1.0×	726 0.6×	495 0.4×	908 1.0×	702 0.8×	160	4.1k
Lee‐Yung Shih Taiwan	30	1.7k 0.8×	663 0.6×	1.2k 1.1×	347 0.4×	776 0.9×	195	3.6k
Guy Touchard France	38	870 0.4×	583 0.5×	2.1k 1.9×	571 0.6×	776 0.9×	163	4.8k
Andreas Buser Switzerland	30	2.9k 1.5×	1.4k 1.2×	2.0k 1.7×	828 0.9×	3.2k 3.9×	151	6.2k
Roshini S. Abraham United States	32	1.2k 0.6×	619 0.5×	1.7k 1.5×	1.7k 1.8×	704 0.8×	126	4.4k
Renato Fanin Italy	42	3.6k 1.8×	2.0k 1.8×	1.4k 1.3×	1.2k 1.3×	1.4k 1.7×	226	6.6k
Carlo Dufour Italy	38	2.9k 1.4×	1.2k 1.0×	1.1k 0.9×	1.2k 1.3×	871 1.0×	174	5.1k
Daniela Damiani Italy	31	1.2k 0.6×	1.1k 1.0×	843 0.7×	451 0.5×	565 0.7×	134	3.0k
Philippe Casassus France	30	3.3k 1.6×	2.0k 1.7×	2.3k 2.1×	674 0.7×	773 0.9×	80	6.1k
H. Heimpel Germany	42	3.7k 1.9×	971 0.8×	798 0.7×	1.1k 1.2×	2.2k 2.7×	308	6.3k

Countries citing papers authored by Andrzej Hellmann

Since Specialization

Citations

This map shows the geographic impact of Andrzej Hellmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrzej Hellmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrzej Hellmann more than expected).

Fields of papers citing papers by Andrzej Hellmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrzej Hellmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrzej Hellmann. The network helps show where Andrzej Hellmann may publish in the future.

Co-authorship network of co-authors of Andrzej Hellmann

This figure shows the co-authorship network connecting the top 25 collaborators of Andrzej Hellmann. A scholar is included among the top collaborators of Andrzej Hellmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrzej Hellmann. Andrzej Hellmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hellmann, Andrzej, et al.. (2024). The European Thyroid Imaging and Reporting Data System as a Remedy for the Overdiagnosis and Overtreatment of Thyroid Cancer: Results from the EUROCRINE Surgical Registry. Cancers. 16(12). 2237–2237. 1 indexed citations

Hellmann, Andrzej, et al.. (2024). The influence of cancer on the reprogramming of lipid metabolism in healthy thyroid tissues of patients with papillary thyroid carcinoma. Endocrine. 87(1). 273–280. 2 indexed citations

Hellmann, Andrzej, et al.. (2023). Alterations in the amino acid profile in patients with papillary thyroid carcinoma with and without Hashimoto’s thyroiditis. Frontiers in Endocrinology. 14. 1199291–1199291. 5 indexed citations

Szymański, M. K., et al.. (2023). Therapeutic challenge: a giant, infiltrating intrathyroidal thymic carcinoma of the thyroid gland. Polskie Archiwum Medycyny Wewnętrznej. 133(6). 1 indexed citations

Proczko-Stepaniak, Monika, et al.. (2022). Kidney Transplantation in Patients After Bariatric Surgery: High-Volume Bariatric and Transplant Center Experience. Transplantation Proceedings. 54(4). 955–959. 5 indexed citations

Wieczór, Miłosz, Grzegorz J. Grabe, Katarzyna Gucwa, et al.. (2021). Effective Drug Concentration and Selectivity Depends on Fraction of Primitive Cells. International Journal of Molecular Sciences. 22(9). 4931–4931. 51 indexed citations

Radich, Jerald P., Andreas Hochhaus, Tamás Masszi, et al.. (2021). Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial. Leukemia. 35(5). 1344–1355. 47 indexed citations

Mital, Andrzej, Andrzej Hellmann, Agnieszka Daca, et al.. (2020). Excessive amount and activity of μ-calpain affects apoptotic machinery in chronic B-cell leukemia cells and influences the course of the disease. Acta Biochimica Polonica. 67(2). 247–257. 2 indexed citations

Hellmann, Andrzej, et al.. (2020). Acute Renal Failure Caused by Giant Inguinoscrotal Bladder Hernia. Urology. 141. 24–26. 1 indexed citations

10.

Felberg, Anna, A Urban, Grzegorz Stasiłojć, et al.. (2019). Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics. Cancer Immunology Immunotherapy. 68(4). 587–598. 12 indexed citations

11.

Grabe, Grzegorz J., Marcin Serocki, Marta Świtalska, et al.. (2018). Cell Density-Dependent Cytological Stage Profile and Its Application for a Screen of Cytostatic Agents Active Toward Leukemic Stem Cells. Stem Cells and Development. 27(7). 488–513. 6 indexed citations

12.

Hellmann, Andrzej, et al.. (2018). Ureteric Stenting in Kidney Transplant Recipients, Gdansk Centre Experience, Poland. Transplantation Proceedings. 50(6). 1858–1862. 7 indexed citations

13.

Hill, Anita, Miles A. Nunn, Tadeusz Robak, et al.. (2017). Coversin, a Novel C5 Complement Inhibitor, Is Safe and Effective in the Treatment of PNH: Results of a Phase II Clinical Trial. Blood. 130. 4747–4747. 4 indexed citations

14.

Hochhaus, Andreas, Philipp le Coutre, L. N. Petrov, et al.. (2017). Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis. Journal of Cancer Research and Clinical Oncology. 143(7). 1225–1233. 6 indexed citations

15.

Zadrożny, Dariusz, et al.. (2015). The Use of Tenckhoff Catheters for Draining of Symptomatic Lymphoceles: A Review of Literature and Our Experience. Transplantation Proceedings. 47(2). 384–387. 5 indexed citations

16.

Dmoszyńska, Anna, Andrzej Hellmann, Trevor Baglin, et al.. (2010). Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A. Haemophilia. 17(2). 185–190. 8 indexed citations

17.

Trzonkowski, Piotr, Jan Maciej Zaucha, Jolanta Myśliwska, et al.. (2004). Differences in Kinetics of Donor Lymphoid Cells in Response to G-CSF Administration May Affect the Incidence and Severity of Acute GvHD in Respective HLA-Identical Sibling Recipients. Medical Oncology. 21(1). 81–94. 10 indexed citations

18.

Hellmann, Andrzej, et al.. (2003). Thalidomide monotherapy or in combination with dexamethasone in patients with refractory multiple myeloma. Contemporary Oncology/Współczesna Onkologia. 5(6). 273–277.

19.

Hryniewicz, Waleria, et al.. (1999). First report of vancomycin-resistant Enterococcus faecium isolated in Poland. Clinical Microbiology and Infection. 5(8). 503–505. 12 indexed citations

20.

Samet, A, et al.. (1999). Isolation and epidemiological study of vancomycin-resistant Enterococcus faecium from patients of a haematological unit in Poland. Journal of Hospital Infection. 41(2). 137–143. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact